{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:16:17Z","timestamp":1786684577717,"version":"build-2736575974"},"reference-count":27,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ruralneuropractice.com"],"crossmark-restriction":true},"short-container-title":["JNRP"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background<\/jats:bold>Cerebral venous thrombosis (CVT) is one of the important causes of stroke in young adults. It is caused by complete or partial thrombotic occlusion of the cerebral venous sinuses or cortical veins. There are many risk factors associated with this condition, out of which common ones are oral contraceptives use, genetic, or acquired thrombophilias, infections, malignancy, pregnancy, and puerperium. We aimed to study the prevalence of inherited procoagulant states in patients with CVT and correlate these states with the severity and outcome.<\/jats:p><jats:p><jats:bold>Materials and Methods<\/jats:bold>\u2003It was a prospective observational study of 2 years duration in which 75 patients, 18 to 50 years old, with confirmed CVT were included. The baseline data, imaging findings were recorded for all the patients. After 3 months of the onset of CVT, anticoagulants were stopped and a procoagulant test was done for all patients. Severity was assessed by Glasgow Coma Score (GCS) at the onset of illness. Functional assessments were done using the modified Rankin Scale (mRS) at presentation, at 7 days, 6 weeks, and 3 months.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>\u2003In the present study, any procoagulant state was seen in 9 out of 75 patients with CVT that accounted for 12% of the total population. There was no significant correlation between the presence of procoagulant states and severity of illness as assessed by GCS at presentation. The presence of any thrombophilia did not affect the final outcome at 7 days, 6 weeks or 3 months (<jats:italic>p<\/jats:italic>\u2009=\u20090.532,<jats:italic>p<\/jats:italic>\u2009=\u20090.944 and<jats:italic>p<\/jats:italic>\u2009=\u20090.965 respectively) as assessed by modified Rankin Scale (mRS).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold>\u2003Inherited procoagulant states are an important risk factor for CVT. The presence of an inherited procoagulant state does not have any correlation with the disease severity and outcome.<\/jats:p>","DOI":"10.1055\/s-0041-1741488","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T23:36:22Z","timestamp":1641598582000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Inherited Procoagulant States in Cerebral Venous Thrombosis and its Correlation with Severity and Outcome"],"prefix":"10.25259","volume":"13","author":[{"given":"Shaman","family":"Gill","sequence":"first","affiliation":[{"name":"Department of Neurology, Command Hospital (Central Command), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Dhull","sequence":"additional","affiliation":[{"name":"Department of Neurology, Command Hospital (Central Command), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aakash Healthcare Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"2","key":"10.1055\/s-0041-1741488\/ref-1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","article-title":"Cerebral venous thrombosis: an update","volume":"6","author":"Bousser","year":"2007","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1055\/s-0041-1741488\/ref-2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/STROKEAHA.113.004666","article-title":"Declining mortality in cerebral venous thrombosis: a systematic review","volume":"45","author":"Coutinho","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"10.1055\/s-0041-1741488\/ref-3","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/STROKEAHA.112.671453","article-title":"The incidence of cerebral venous thrombosis: a cross-sectional study","volume":"43","author":"Coutinho","year":"2012","journal-title":"Stroke"},{"issue":"4","key":"10.1055\/s-0041-1741488\/ref-4","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1055\/s-0041-1741488\/ref-5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"issue":"2","key":"10.1055\/s-0041-1741488\/ref-6","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/STROKEAHA.113.003964","article-title":"Cerebral venous thrombosis: diagnosis and management","volume":"45","author":"Gulati","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1055\/s-0041-1741488\/ref-7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/STROKEAHA.110.602672","article-title":"Genes associated with adult cerebral venous thrombosis","volume":"42","author":"Marjot","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"10.1055\/s-0041-1741488\/ref-8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/01.STR.29.7.1398","article-title":"Frequency of the 20210 G\u2013>A mutation in the 3\u2032-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis","volume":"29","author":"Biousse","year":"1998","journal-title":"Stroke"},{"issue":"4","key":"10.1055\/s-0041-1741488\/ref-9","first-page":"CD002005","article-title":"Anticoagulation for cerebral sinus thrombosis","author":"Stam","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1055\/s-0041-1741488\/ref-10","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1468-1331.2012.03690.x","article-title":"Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial","volume":"19","author":"Misra","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1055\/s-0041-1741488\/ref-11","first-page":"CD001100","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism","volume":"2","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1055\/s-0041-1741488\/ref-12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1538-7836.2010.03799.x","article-title":"How to treat cerebral venous and sinus thrombosis","volume":"8","author":"Coutinho","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1055\/s-0041-1741488\/ref-13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MBC.0b013e32835fad1e","article-title":"Hereditary thrombophilia in cerebral venous thrombosis: a study from India","volume":"24","author":"Pai","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1055\/s-0041-1741488\/ref-14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/0028-3886.96388","article-title":"Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: insights from Nizam's Institute Venous Stroke Registry, Hyderabad (India)","volume":"60","author":"Narayan","year":"2012","journal-title":"Neurol India"},{"key":"10.1055\/s-0041-1741488\/ref-15","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1007\/s10072-004-0287-3","article-title":"Headache in cerebral venous thrombosis","volume":"25","author":"Agostoni","year":"2004","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1055\/s-0041-1741488\/ref-16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","article-title":"Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list","volume":"92","author":"Do","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1055\/s-0041-1741488\/ref-17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/practneurol-2019-002415","article-title":"Cerebral venous thrombosis: a practical guide","volume":"20","author":"Ulivi","year":"2020","journal-title":"Pract Neurol"},{"issue":"12","key":"10.1055\/s-0041-1741488\/ref-18","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/01.STR.29.12.2649","article-title":"Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis","volume":"29","author":"Corvol","year":"1998","journal-title":"Stroke"},{"issue":"6","key":"10.1055\/s-0041-1741488\/ref-19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00234-002-0772-4","article-title":"Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis","volume":"44","author":"Yoshikawa","year":"2002","journal-title":"Neuroradiology"},{"issue":"12","key":"10.1055\/s-0041-1741488\/ref-20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.diii.2014.10.006","article-title":"Imaging of cerebral venous thrombosis","volume":"95","author":"Bonneville","year":"2014","journal-title":"Diagn Interv Imaging"},{"issue":"10","key":"10.1055\/s-0041-1741488\/ref-21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.STR.27.10.1724","article-title":"Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis","volume":"27","author":"Deschiens","year":"1996","journal-title":"Stroke"},{"issue":"25","key":"10.1055\/s-0041-1741488\/ref-22","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJM199806183382502","article-title":"High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives","volume":"338","author":"Martinelli","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1055\/s-0041-1741488\/ref-23","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/01.STR.29.12.2507","article-title":"Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients","volume":"29","author":"L\u00fcdemann","year":"1998","journal-title":"Stroke"},{"issue":"9","key":"10.1055\/s-0041-1741488\/ref-24","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.STR.29.9.1765","article-title":"Prothrombin gene G20210\u2013>A transition is a risk factor for cerebral venous thrombosis","volume":"29","author":"Reuner","year":"1998","journal-title":"Stroke"},{"issue":"10","key":"10.1055\/s-0041-1741488\/ref-25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/qjmed\/91.10.677","article-title":"Inherited prothrombotic risk factors and cerebral venous thrombosis","volume":"91","author":"Hillier","year":"1998","journal-title":"QJM"},{"issue":"8","key":"10.1055\/s-0041-1741488\/ref-26","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.020","article-title":"A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study","volume":"26","author":"Duman","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"10.1055\/s-0041-1741488\/ref-27","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ruralneuropractice.com\/prevalence-of-inherited-procoagulant-states-in-cerebral-venous-thrombosis-and-its-correlation-with-severity-and-outcome\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ruralneuropractice.com\/prevalence-of-inherited-procoagulant-states-in-cerebral-venous-thrombosis-and-its-correlation-with-severity-and-outcome\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T04:39:45Z","timestamp":1691210385000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/prevalence-of-inherited-procoagulant-states-in-cerebral-venous-thrombosis-and-its-correlation-with-severity-and-outcome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":27,"alternative-id":["10.1055\/s-0041-1741488"],"URL":"https:\/\/doi.org\/10.1055\/s-0041-1741488","relation":{},"ISSN":["0976-3147"],"issn-type":[{"value":"0976-3147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"article-number":"67"}}